HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants

[1]  J. Macdonald,et al.  Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. , 2015, The Cochrane database of systematic reviews.

[2]  Robert L Grant,et al.  Converting an odds ratio to a range of plausible relative risks for better communication of research findings , 2014, BMJ : British Medical Journal.

[3]  R. Toes,et al.  A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis , 2013, The Journal of experimental medicine.

[4]  J. Mary,et al.  Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. , 2013, Gastroenterology.

[5]  Buhm Han,et al.  Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.

[6]  J. Mate,et al.  Safety of Thiopurine Therapy in Inflammatory Bowel Disease: Long-term Follow-up Study of 3931 Patients , 2013, Inflammatory bowel diseases.

[7]  James McCluskey,et al.  Human leukocyte antigen-associated drug hypersensitivity. , 2013, Current opinion in immunology.

[8]  Patrick F. Sullivan,et al.  zCall: a rare variant caller for array-based genotyping: Genetics and population analysis , 2012, Bioinform..

[9]  J. Marchini,et al.  Fast and accurate genotype imputation in genome-wide association studies through pre-phasing , 2012, Nature Genetics.

[10]  J. McCluskey,et al.  Immune self-reactivity triggered by drug-modified HLA-peptide repertoire , 2012, Nature.

[11]  M. Pirmohamed,et al.  Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool , 2011, PloS one.

[12]  Jim Leape,et al.  Invasives: a major conservation threat. , 2011, Science.

[13]  K. King,et al.  HLA-DQA1*02:01 is a major risk factor for lapatinib-induced hepatotoxicity in women with advanced breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  P. Visscher,et al.  GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.

[15]  G. Abecasis,et al.  MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes , 2010, Genetic epidemiology.

[16]  Josyf Mychaleckyj,et al.  Robust relationship inference in genome-wide association studies , 2010, Bioinform..

[17]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[18]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[19]  Simon C. Potter,et al.  Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region , 2009, Nature Genetics.

[20]  M. Daly,et al.  HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin , 2009, Nature Genetics.

[21]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[22]  Judy H. Cho,et al.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.

[23]  A Jawaid,et al.  Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis , 2008, The Pharmacogenomics Journal.

[24]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[25]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[26]  W. Steinberg,et al.  Drug-Induced Acute Pancreatitis: An Evidence-Based Review , 2007 .

[27]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[28]  R. Gearry,et al.  Thiopurine drug adverse effects in a population of New Zealand patients with inflammatory bowel disease , 2004, Pharmacoepidemiology and drug safety.

[29]  C. Lewis,et al.  Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). , 2004, Pharmacogenetics.

[30]  A. Oliphant,et al.  BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. , 2002, BioTechniques.

[31]  T. Ahmad,et al.  The molecular classification of the clinical manifestations of Crohn's disease. , 2002, Gastroenterology.

[32]  M. Freedman,et al.  Acute pancreatitis as a complication of Imuran therapy in regional enteritis. , 1972, Gastroenterology.

[33]  S. Pandya,et al.  An Evidence-Based Review , 2012 .

[34]  Yao Ju,et al.  HLA-B~*5701 screening for hypersensitivity to abacavir , 2011 .

[35]  M. Cepoiu,et al.  Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. , 2009, The Cochrane database of systematic reviews.

[36]  Helen Schuilenburg,et al.  Genome-wide association study and meta-analysis finds over 40 loci affect risk of type 1 diabetes , 2009, Nature Genetics.

[37]  A. Timmer,et al.  Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. , 2007, The Cochrane database of systematic reviews.

[38]  J. Malley,et al.  Younger Adults' Understanding of Questions for a Service User Experience Survey. Funded/commissioned by: The Health and Social Care Information Centre , 2006 .

[39]  J. Collins,et al.  Hemorrhagic pancreatitis: a fatal complication of renal transplantation , 1967 .